Want to join the conversation?
$CERN 2Q15 Call: The total YoverY growth for each expense category on non-GAAP basis: 32% for sales & client service, 42% for software development, 61% for G&A, a 3% decline in amortization of acquisition related intangibles. GAAP net earnings were $115MM or $0.33 per diluted share & adjusted were $183MM or $0.52, which is up 30% compared to 2Q14.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?